Literature DB >> 8546881

Effects of metals on elastase from Pseudomonas aeruginosa SES-938-1.

S Kocabiyik1, E Ergin, S Turkoglu.   

Abstract

Among the numerous virulance factors produced by Pseudomonas aeruginosa, elastase is the one most often associated with pathogenesis. In this study, effects of various metal ions on elastase from a new isolate of P. aeruginosa (Strain SES-938-1) was investigated. Crude elastase was prepared from culture supernatant via salting out by ammonium sulfate, and then desalting and concentrating the sample using a centricon microconcentrator. Activities were measured at 450 nm using N-succinyl-L-(ala)3-p-nitroanilide as the substrate. The metal chelating agents EDTA and EGTA inhibited the Pseudomonas elastase, which shows that the enzyme is a typical metalloproteinase. At a 10-mM concentration, Mn2+, Ni2+, and Zn2+ strongly inhibited the elastase, whereas Mg2+ effect was negligable. There was a gradual decrease in the enzyme activity in accordance with an increase in the concentration of metal ions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546881     DOI: 10.1007/BF02789146

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  13 in total

1.  Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease.

Authors:  L W Heck; K Morihara; D R Abrahamson
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

2.  Efficient production and processing of elastase and LasA by Pseudomonas aeruginosa require zinc and calcium ions.

Authors:  J C Olson; D E Ohman
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

3.  Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.

Authors:  L W Heck; K Morihara; W B McRae; E J Miller
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

4.  The synthesis and analytical use of a highly sensitive and convenient substrate of elastase.

Authors:  J Bieth; B Spiess; C G Wermuth
Journal:  Biochem Med       Date:  1974-12

5.  Demonstration of a cell-associated, inactive precursor of an exocellular protease produced by Pseudomonas aeruginosa.

Authors:  S E Jensen; I T Fecycz; G W Stemke; J N Campbell
Journal:  Can J Microbiol       Date:  1980-01       Impact factor: 2.419

6.  Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor.

Authors:  K Morihara; H Tsuzuki; K Oda
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene.

Authors:  R A Bever; B H Iglewski
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

8.  Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: elastase, an IgG protease.

Authors:  I A Holder; R Wheeler
Journal:  Can J Microbiol       Date:  1984-09       Impact factor: 2.419

9.  In vitro inhibition of Pseudomonas aeruginosa elastase by metal-chelating peptide derivatives.

Authors:  E Kessler; M Israel; N Landshman; A Chechick; S Blumberg
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors.

Authors:  D R Schultz; K D Miller
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  1 in total

1.  Disarming Pseudomonas aeruginosa Virulence by the Inhibitory Action of 1,10-Phenanthroline-5,6-Dione-Based Compounds: Elastase B (LasB) as a Chemotherapeutic Target.

Authors:  Anna Clara M Galdino; Lívia Viganor; Alexandre A de Castro; Elaine F F da Cunha; Thaís P Mello; Larissa M Mattos; Marcos D Pereira; Mary C Hunt; Megan O'Shaughnessy; Orla Howe; Michael Devereux; Malachy McCann; Teodorico C Ramalho; Marta H Branquinha; André L S Santos
Journal:  Front Microbiol       Date:  2019-08-02       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.